Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Text Size
4 studies found for:    19179464 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting Optimising Renal Outcome in Myeloma Renal Failure
Conditions: Multiple Myeloma;   Chronic Kidney Disease
Interventions: Drug: Bortezomib;   Drug: Thalidomide;   Drug: Bendamustine;   Drug: Dexamethasone
2 Active, not recruiting Lenalidomide Maintenance Therapy for Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: Lenalidomide
3 Terminated
Has Results 		A Phase II Trial of Anti-KIR in Smoldering Multiple Myeloma
Conditions: Multiple Myeloma;   Myeloma;   Smoldering Multiple Myeloma
Intervention: Drug: (Anti-KIR)
4 Completed Natural History Study of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Myeloma (SMM)
Conditions: Smoldering Myeloma;   Monoclonal Gammopathy of Undetermined Significance
Intervention:
To Top

† Indicates status has not been verified in more than two years